Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
Abstract Ovarian cancer is the fifth leading cause of cancer-related mortality in women worldwide. Despite the development of technologies over decades to improve the diagnosis and treatment of patients with ovarian cancer, the survival rate remains dismal, mainly because most patients are diagnosed...
Guardado en:
Autores principales: | Fang Yang, Jun Tang, Zihao Zhao, Chunling Zhao, Yuancai Xiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4fb9c17614df4d99840629e535b29309 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction to: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: a retrospective study according to the POSEIDON criteria
por: Marzieh Farimani, et al.
Publicado: (2021) -
Circulating noncoding RNAs as early predictive biomarkers in preeclampsia: a diagnostic meta-analysis
por: Sha Su, et al.
Publicado: (2021) -
CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis
por: Yuping Du, et al.
Publicado: (2021) -
Icariin improves testicular dysfunction via enhancing proliferation and inhibiting mitochondria-dependent apoptosis pathway in high-fat diet and streptozotocin-induced diabetic rats
por: Weiguo He, et al.
Publicado: (2021) -
Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Afsoon Zareii, et al.
Publicado: (2021)